title: Emerging benefits of AT1 receptor antagonists with pleiotropic anti-inflammatory activity.
authors.affiliation: School of Biomedical Sciences, The University of Queensland, Brisbane, Australia.
authors.forename: Conrad
authors.initials: C
authors.lastname: Sernia
authors.forename: Lindsay
authors.initials: L
authors.lastname: Brown
mesh_terms: D000818:Animals; D001562:Benzimidazoles / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D007674:Kidney Diseases / Q000517:prevention & control*; D008297:Male; D024821:Metabolic Syndrome / Q000503:physiopathology*; D000077333:Telmisartan; D013777:Tetrazoles / Q000627:therapeutic use*; D014633:Valine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000068756:Valsartan
chemical_list: D001562:Benzimidazoles; D001565:Benzoates; D013777:Tetrazoles; D000068756:Valsartan; D014633:Valine; D000077333:Telmisartan